The following is a round-up of earnings by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
----------
IQ-AI Ltd - Jersey-based medical services firm - Revenue for 2022 is £535,886, up 2.8% from £521,069 the year prior. Pretax loss is £511,601, widening from £501,058. Loss per share narrows slightly to 0.28p per share, from a loss of 0.29p a year ago. Says focus is on converting as many of its trial sites to long term customers. Says it does not believe that IQ-AI’s current market value is a reflection of the accretion of value over the past five years.
----------
Creo Medical Group PLC - Chepstow, Wales-based medical device company focused on the field of surgical endoscopy - Revenue grows 8.0% to £27.2 million, from £25.2 million in 2021. Says it has ‘made significant progress in establishing sales channels through new products, as well as the development of our commercial footprint’. Pretax loss is £31.0 million, widening from £30.3 million. declares no dividend, unchanged from a year ago. Chief Executive Craig Gulliford says: ‘We expect to see the continued acceleration of the commercialisation of our core technology and the introduction of new innovative products, as well as the expansion of our Kamaptive programme as we continue to build a world class medical device and tech licensing company.’
----------
M&G Credit Income Investment Trust PLC - debt investment firm - Net asset value per share at December 31 94.99 pence, down 6.4% from 101.44p in at December 31 the year prior due to a widening of credit spreads, rather than interest rate rises. NAV total return of negative 2.8%, swinging from a return of 13%. Declares dividend of 5.35p per share ‘in spite of the company‘s underperformance’, increasing 32% from 4.04p a year ago, ‘to reflect’ the confidence of its investment manager. Says it expects a rise in NAV as credit spreads normalise.
----------
Third Point Investors Ltd - feeder fund that invests in the Third Point Offshore Fund - Net asset value per share at December 31 $24.46, down 24% from $32.37. Returns negative 24% on NAV total return basis, returns negative 26% on share price basis. Notes that ‘most all asset classes performed poorly’, seeing significant losses in all sectors. ‘While 2022 was extremely disappointing from a performance perspective, the investment manager is encouraged that the opportunity set currently presented is highly attractive for capitalising on its many strategies employed, including security selection and specialist credit,’ comments Chair Rupert Dorey.
----------
Copyright 2023 Alliance News Ltd. All Rights Reserved.
